Amanda Calvert and Michael Whitehouse OBE have been re-appointed as Non-Executive Directors of the Medicines and Healthcare products Regulatory Agency (MHRA), from 1 September 2023.
Ms Calvert's term of appointment will run for two years until 31 August 2025. Mr Whitehouse's term of appointment will run for three years until 31 August 2026. He has also been re-appointed as the Audit and Risk Assurance Committee Chair of the Agency for the same period.
Notes
- These Non-Executive Director appointments are made by Ministers in accordance with the Cabinet Office Code of Governance for Public Appointments. The regulation of public appointments against the requirements of this Code is carried out by the Commissioner for Public Appointments.
- For full details regarding these appointments, please refer to the announcement made by the Department for Health and Social Care.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
